Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rescue Therapy for Helicobacter Pylori Eradication: A Randomized and Non-inferiority Trail of Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy

NCT03609892 is registered in ClinicalTrials.gov with Xijing Hospital of Digestive Diseases as lead sponsor.

NCT NCT03609892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03609892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rescue Therapy for Helicobacter Pylori Eradication: A Randomized and Non-inferiority Trail of Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy
Lead sponsor
Xijing Hospital of Digestive Diseases
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2018
Completion date
August 20, 2019
Enrollment
658 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic gastritis, gastric cancer, gastric ulcer, gastritis, helicobacter pylori infection